Among patients with multiple sclerosis (MS), fatigue is the most commonly reported
symptom, and one of the most debilitating. Despite its high prevalence and significant …

Cannabis sativa L. has been utilized for treatment of pain and sleep disorders since ancient
times. This review examines modern studies on effects of Δ9‐tetrahydrocannabinol (THC) …

Objective: The coronavirus disease 2019 (COVID-19) has radically changed the world in a
few weeks. Italy has been one of the first and most affected countries with more than 30,000 …

The aim of this study was to investigate the prevalence of symptoms of depression and
anxiety amongst multiple sclerosis (MS) patients, and the associations with demographic …

Objectives To systematically review and synthesize literature on 1) the overall prevalence of
depression and anxiety in SLE patients in identified studies, and 2) the pooled prevalence …

OBJECTIVE: Apathy is highly prevalent among neuropsychiatric populations and is
associated with greater morbidity and worse functional outcomes. Despite this, it remains …

Purpose/Objective: Disability identity involves affirming one's status as a person with a
disability and incorporating this group membership into one's identity. It is associated with …

Neuropsychiatric symptoms are common in multiple sclerosis (MS). They include two broad
categories of disturbances: abnormalities in cognition, and abnormalities of mood, affect and …

Background In the 24-month MS-STAT phase 2 trial, we showed that high-dose simvastatin
significantly reduced the annualised rate of whole brain atrophy in patients with secondary …

Apathy is an increasingly recognized concomitant of a broad range of central nervous
system disorders. Nevertheless, its nosology, pathogenesis and therapy remain shrouded in …